Credo Technology Group Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Credo Technology Group Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-08-02 | 2025-05-03 | 2025-02-01 | 2024-11-02 | 2024-08-03 | 2024-04-27 | 2024-01-27 | 2023-10-28 | 2023-07-29 | 2023-04-29 | 2023-01-28 | 2022-10-29 | 2022-07-30 | 2022-04-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||
net income | 63,399,000 | 36,588,000 | 29,360,000 | -4,225,000 | -9,540,000 | -10,477,000 | 428,000 | -6,623,000 | -11,697,000 | -15,937,000 | 2,823,000 | -3,360,000 | -73,000 | -5,355,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||
depreciation and amortization | 5,460,000 | 7,657,000 | 5,063,000 | 4,985,000 | 4,233,000 | 3,686,000 | 3,437,000 | 3,698,000 | 2,950,000 | 2,981,000 | 2,273,000 | 2,624,000 | 1,636,000 | 1,531,000 |
share-based compensation | 35,455,000 | 27,862,000 | 16,190,000 | 16,663,000 | 16,640,000 | 14,578,000 | 8,332,000 | 8,144,000 | 7,968,000 | 7,910,000 | 5,169,000 | 4,891,000 | 5,546,000 | 5,368,000 |
warrant contra revenue | 0 | 7,358,000 | 2,610,000 | 3,218,000 | 2,102,000 | 1,033,000 | 354,000 | 436,000 | 325,000 | 260,000 | 247,000 | 388,000 | 233,000 | |
write-downs (releases) for excess and obsolete inventory | 1,993,000 | -298,000 | ||||||||||||
changes in operating assets and liabilities: | ||||||||||||||
accounts receivable | -19,059,000 | -5,011,000 | -75,357,000 | -9,917,000 | -12,197,000 | -14,902,000 | -12,037,000 | -4,756,000 | 21,574,000 | -6,373,000 | 8,600,000 | 3,001,000 | -25,245,000 | -7,830,000 |
inventories | -27,513,000 | -38,793,000 | -19,066,000 | -7,259,000 | -5,352,000 | 1,913,000 | 4,297,000 | 4,503,000 | 5,049,000 | 1,686,000 | -4,471,000 | -10,989,000 | -10,605,000 | -1,403,000 |
other current assets | 3,940,000 | |||||||||||||
other non-current assets | 495,000 | 461,000 | 412,000 | 569,000 | 647,000 | 6,744,000 | -2,792,000 | -2,101,000 | -2,505,000 | -2,379,000 | -4,600,000 | -438,000 | -560,000 | 510,000 |
accounts payable | -8,962,000 | 19,587,000 | 23,772,000 | -7,218,000 | 5,789,000 | 3,525,000 | -280,000 | 3,078,000 | 2,483,000 | -15,546,000 | 1,630,000 | 359,000 | 9,714,000 | 1,503,000 |
accrued compensation and benefits, other current liabilities and other non-current liabilities | -1,040,000 | |||||||||||||
net cash from operating activities | 54,168,000 | 57,822,000 | 4,212,000 | 10,285,000 | -7,236,000 | 4,157,000 | -1,036,000 | 5,008,000 | 24,608,000 | -11,839,000 | -2,314,000 | 1,757,000 | -12,219,000 | 2,360,000 |
capex | 6,859,000 | -3,619,000 | -3,720,000 | -41,302,000 | 21,457,000 | -3,675,000 | -6,117,000 | 2,496,000 | -69,000 | -3,778,000 | -10,614,000 | -3,898,000 | 7,486,000 | -9,648,000 |
free cash flows | 61,027,000 | 54,203,000 | 492,000 | -31,017,000 | 14,221,000 | 482,000 | -7,153,000 | 7,504,000 | 24,539,000 | -15,617,000 | -12,928,000 | -2,141,000 | -4,733,000 | -7,288,000 |
cash flows from investing activities: | ||||||||||||||
purchases of property and equipment | -2,821,000 | -3,655,000 | -4,595,000 | -21,948,000 | -5,863,000 | -3,195,000 | -5,100,000 | -2,045,000 | -5,312,000 | -3,898,000 | -6,890,000 | -5,667,000 | -5,258,000 | -9,648,000 |
maturities of short-term investments | 50,000,000 | 30,000,000 | 63,716,000 | 151,000,000 | 162,061,000 | 0 | 60,526,000 | 50,000,000 | 59,228,000 | |||||
purchases of short-term investments | -115,000,000 | -145,010,000 | 0 | 0 | -113,716,000 | -30,000,000 | -262,061,000 | -51,000,000 | -60,526,000 | -50,000,000 | -59,228,000 | |||
net cash from investing activities | -67,821,000 | -118,665,000 | 59,121,000 | 129,052,000 | 42,482,000 | -33,195,000 | -206,635,000 | -3,045,000 | -6,610,000 | -3,898,000 | -66,118,000 | -55,667,000 | -5,258,000 | -9,648,000 |
cash flows from financing activities: | ||||||||||||||
payments on technology license obligations | -3,906,000 | -912,000 | -838,000 | -3,718,000 | -838,000 | 0 | 0 | -326,000 | -2,726,000 | -308,000 | ||||
proceeds from employee share incentive plans | 4,648,000 | 1,034,000 | 2,413,000 | 871,000 | 3,513,000 | 906,000 | 1,872,000 | 746,000 | 1,977,000 | |||||
tax withheld related to rsu settlement | -3,712,000 | -2,094,000 | -4,909,000 | -1,179,000 | -1,071,000 | |||||||||
net cash from financing activities | -2,970,000 | -1,972,000 | -3,334,000 | -4,026,000 | 1,604,000 | 7,000 | 174,605,000 | 130,000 | 534,000 | 598,000 | 1,564,000 | 746,000 | 1,977,000 | 26,167,000 |
effect of exchange rate changes on cash | -69,000 | -65,000 | -28,000 | 26,000 | 108,000 | -100,000 | 153,000 | -152,000 | -70,000 | -61,000 | 109,000 | -77,000 | -39,000 | -86,000 |
net increase in cash and cash equivalents | -16,692,000 | -62,880,000 | 59,971,000 | 135,337,000 | 36,958,000 | -29,131,000 | -32,913,000 | 1,941,000 | 18,462,000 | 18,793,000 | ||||
cash and cash equivalents at beginning of the period | 236,328,000 | 0 | 0 | 66,942,000 | 0 | 0 | 108,583,000 | 0 | 0 | 259,322,000 | ||||
cash and cash equivalents at end of the period | 219,636,000 | 59,971,000 | 135,337,000 | 103,900,000 | -32,913,000 | 1,941,000 | 127,045,000 | -66,759,000 | -53,241,000 | 243,783,000 | ||||
supplemental cash flow information: | ||||||||||||||
purchases of property and equipment included in accounts payable, other current liabilities and other non-current liabilities | 9,680,000 | |||||||||||||
write-downs for excess and obsolete inventory | 3,599,000 | 2,148,000 | 3,687,000 | -43,000 | 529,000 | 181,000 | 2,606,000 | 1,985,000 | 191,000 | 911,000 | 188,000 | |||
impairment of assets | 0 | |||||||||||||
changes in operating assets and liabilities | ||||||||||||||
accrued compensation and other liabilities | ||||||||||||||
proceeds from issuance of ordinary shares in connection with public offering, net of offering costs | ||||||||||||||
cash and cash equivalents at beginning of the year | ||||||||||||||
cash and cash equivalents at end of the year | ||||||||||||||
income taxes paid | ||||||||||||||
purchases of property and equipment included in accounts payable, accrued expenses and other liabilities | 36,000 | 875,000 | -19,354,000 | 27,320,000 | -480,000 | -1,017,000 | 4,541,000 | 5,243,000 | ||||||
contract assets | 6,392,000 | 4,423,000 | -2,838,000 | -3,653,000 | -5,867,000 | -3,994,000 | 1,397,000 | 10,794,000 | -12,814,000 | -411,000 | 4,040,000 | |||
prepaid and other current assets | 1,240,000 | -1,312,000 | -2,790,000 | -4,998,000 | -855,000 | -1,007,000 | -859,000 | -1,130,000 | -1,047,000 | 1,149,000 | 1,540,000 | 3,393,000 | ||
accrued expenses, compensation and other liabilities | 7,343,000 | 9,344,000 | -3,662,000 | 2,163,000 | 3,430,000 | 1,629,000 | -1,519,000 | 2,341,000 | -6,677,000 | 6,108,000 | -1,281,000 | 3,711,000 | ||
deferred revenue | -643,000 | -881,000 | -1,086,000 | -976,000 | -119,000 | 1,554,000 | -850,000 | 883,000 | 2,148,000 | -1,615,000 | 1,770,000 | |||
proceeds from issuance of ordinary share in connection with public offering, net of underwriter discounts and offering costs | ||||||||||||||
proceeds from issuance of convertible preferred shares, net of issuance costs | 0 | |||||||||||||
conversion of convertible preferred shares into ordinary shares upon initial public offering | ||||||||||||||
proceeds from employee share incentive plans, net of tax withholding related to vesting of rsus | 969,000 | |||||||||||||
proceeds from employee share incentive plans, net of tax withholding related to vesting of rsu | 3,260,000 | |||||||||||||
proceeds from issuance of ordinary shares upon initial public offering, net of underwriter discounts and offering costs | ||||||||||||||
payments for repurchase of ordinary shares | ||||||||||||||
purchase of property and equipment included in accounts payable, accrued expenses and other liabilities | 120,000 | -3,724,000 | 1,769,000 | 12,744,000 | ||||||||||
proceeds from issuance of ordinary share upon initial public offering, net of underwriter discounts | ||||||||||||||
payments for ipo offering costs | ||||||||||||||
net decrease in cash and cash equivalents | -66,759,000 | -53,241,000 | -15,539,000 | |||||||||||
conversion of convertible preferred share into ordinary share upon initial public offering | 0 | |||||||||||||
deferred offering costs included in accounts payable and accrued expenses | ||||||||||||||
deferred revenue, net of contract assets | -4,376,000 | |||||||||||||
proceeds from employee stock options exercises | 795,000 | |||||||||||||
property and equipment received and accrued in accounts payable | -32,000 | |||||||||||||
proceeds from issuance of ordinary shares upon initial public offering, net of underwriter discounts | ||||||||||||||
payments for deferred offering costs |
We provide you with 20 years of cash flow statements for Credo Technology Group stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Credo Technology Group stock. Explore the full financial landscape of Credo Technology Group stock with our expertly curated income statements.
The information provided in this report about Credo Technology Group stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.